Skip to main content
OpenTrials
Completed

NCT Number: NCT00740025

Once Daily vs Twice Daily Administration of Gonadotropins in Assisted Reproductive Technologies (ART)

This is a prospective randomized study evaluating dosing frequency of gonadotropin administration in ART cycles.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pregnancy

Age range

21 year–39 year

Sex eligibility

Female

Study type

Observational

Primary location

Virginia Center for Reproductive Medicine

Reston, Virginia, 20190, United States

About this study

Using once daily or bid dosing of gonadotropins in ART has been arbitrary with no studies showing whether splitting the medication dose improves ART parameters. This study was undertaken to provide an answer to this important question.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • women < 40 undergoing ART

Exclusion criteria

  • women > 40
  • endometriomas
  • severe cervical stenosis
  • testicular sperm

Treatment and study plan

Primary outcomes

  1. Ongoing pregnancy

    Time frame: 1 year

Secondary outcomes

  1. peak estradiol, number of follicles, number of oocytes, implantation rate, multiple pregnancy rate

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Virginia Center for Reproductive Medicine

Other

Registry information

Official study title

A Prospective Randomized Study of QD vs BID Dosing in ART

Acronym: QD vs BID

Important dates

Study start
2006
Primary completion
2010
Study completion
2010
First posted
Aug 22, 2008
Registry last updated
Oct 14, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.